Can you really “shop around” for healthcare?

For most people in Southern Oregon, the answer is no.

In this episode of Reimagine Healthcare, Noah Volz breaks down one of the most misleading ideas in American health policy: the belief that healthcare works like a normal market.

A real market requires clear prices, meaningful competition, time to compare options, and the ability to walk away. Healthcare often gives patients the opposite: no real price upfront, limited provider choice, urgent decisions, insurance complexity, and a massive knowledge gap between patient and clinician.

And in Southern Oregon, the problem is even more concrete.

Asante is the dominant healthcare system across much of the Rogue Valley and surrounding region. For many patients in Jackson and Josephine counties, “choice” often means choosing which part of the same large system has an opening — or traveling hours for alternatives.

This episode looks at why healthcare fails every major market test, including:

• Why patients cannot evaluate medical care like normal consumers
• Why prices often do not change healthcare behavior the way they do in other markets
• How insurance weakens normal price signals
• Why emergency care removes consumer choice completely
• How hospital consolidation changes local bargaining power
• Why the Ashland Community Hospital transition reveals an accountability problem
• Why healthcare is closer to a utility than a consumer marketplace
• What Oregon legislation could do about price transparency, facility fees, and corporate control of medicine

The episode also gives listeners practical steps, including how to ask for cash prices, request cost estimates, use community health centers, appeal insurance denials, explore OHP Bridge, and contact Oregon legislators about healthcare accountability bills.

The central takeaway is simple:

Southern Oregon does not need more market theater. It needs real healthcare accountability.

Subscribe at reimagine-healthcare.org for plain-English healthcare analysis rooted in Southern Oregon.

This podcast is for educational purposes only and is not medical advice.

Why does medicine sometimes stay stuck on outdated ideas, even when better evidence is available?

In this final episode of the Blind Spots in Medicine series, Noah Volz looks beneath the individual examples — appendicitis, peanut allergy, antibiotics, and the microbiome — and asks a deeper question:

How are doctors trained to think?

This episode explores how medical education can reward memorization, hierarchy, speed, and the performance of certainty, while leaving too little room for curiosity, humility, probability, and thoughtful uncertainty.

That matters because medicine is rarely as simple as true or false. Good clinical thinking often sounds more like: How confident are we? What are the tradeoffs? What would make us change course? What is the smartest next step for this specific person?

This is not an anti-doctor episode. Most physicians in Southern Oregon are working inside conditions they did not create: short visits, workforce shortages, prior authorizations, endless documentation, burnout, and increasingly complex patient needs.

But when a training system suppresses curiosity, a payment system rewards volume, and a healthcare workforce has too little time for careful thinking, blind spots can persist.

In this episode, you’ll learn:

• Why medical training can produce both competence and rigidity
• How memorization and testing shape medical culture
• Why probability-based thinking matters in healthcare
• How hierarchy and certainty can make updating harder
• Why Southern Oregon feels these national training patterns locally
• Why prevention, lifestyle medicine, nutrition, sleep, and whole-person care often remain underdeveloped
• How patients can ask better questions without becoming adversarial
• Why good medicine is not always more testing, more treatment, or more certainty

The core message is simple:

A better patient is not a more suspicious patient. A better patient is a more prepared patient.

And better medicine starts with better questions.

Subscribe at reimagine-healthcare.org for plain-English healthcare analysis rooted in Southern Oregon.

This podcast is for educational purposes only and is not medical advice.

Antibiotics are one of the greatest tools in medical history.

They save lives. They have saved millions of lives. If you have bacterial meningitis, sepsis, worsening pneumonia, or a serious skin infection, you want antibiotics quickly.

But what happens when a life-saving tool becomes normalized, overused, and prescribed in situations where the benefit is small, uncertain, or nonexistent?

In this episode of Reimagine Healthcare, Noah Volz continues the Blind Spots in Medicine series with a closer look at antibiotics, children’s health, the microbiome, and the medical culture that can turn powerful interventions into reflexes.

This is not an anti-antibiotic episode. It is an episode about using antibiotics with more care.

The microbiome is not just a random collection of bacteria. It helps shape digestion, immune function, inflammation, metabolism, and possibly even gut-brain signaling. In early childhood, that microbial environment is still being built. Antibiotics can be necessary and lifesaving, but they can also disrupt that ecosystem.

The real issue is not antibiotics. The real issue is unnecessary antibiotics.

This episode explains why parents often end up with prescriptions even when a child’s illness may be viral, why urgent care and rushed visits can increase prescribing pressure, and why regions like Southern Oregon may be especially vulnerable when primary care access is tight and follow-up is hard.

In this episode, you’ll learn:

• Why antibiotics deserve respect, not fear
• What the microbiome does and why early childhood may matter
• Why unnecessary antibiotics are not neutral
• What observational research can and cannot prove about antibiotics and later health risks
• How antibiotic resistance creates a community-wide problem
• Why urgent care, parent pressure, liability concerns, and limited follow-up can lead to overprescribing
• What Southern Oregon families should ask before accepting an antibiotic prescription
• When waiting may be reasonable — and when prompt medical care matters

The key takeaway is simple:

When antibiotics are clearly needed, they are a gift. When they are not clearly needed, asking better questions is not anti-medicine. It is good medicine.

Subscribe at reimagine-healthcare.org for plain-English healthcare analysis rooted in Southern Oregon.

This podcast is for educational purposes only and is not medical advice. If your child is seriously ill, worsening, or showing red-flag symptoms, seek medical care promptly.

How can a medical recommendation that harms people survive for years inside one of the most educated, evidence-focused professions in the world?

In this episode of Reimagine Healthcare, Noah Volz begins a three-part series on what Dr. Marty Makary calls blind spots in medicine — the places where healthcare gets stuck on ideas that are incomplete, outdated, or wrong.

This is not an anti-doctor episode. It is a systems episode.

Medicine is a human system. And human systems have failure modes: cognitive dissonance, professional identity, protocols, liability fear, institutional embarrassment, habit, and the pressure to move quickly through busy clinical settings.

This episode uses two examples to make the problem concrete: appendicitis and peanut allergy.

For more than a century, appendicitis was treated with one dominant reflex: remove the appendix. But research has shown that some uncomplicated cases may be managed with antibiotics first. That does not mean surgery is obsolete. It means patients should understand when there is a real choice.

The peanut allergy story is even more uncomfortable. Around the year 2000, major guidance encouraged peanut avoidance for young children and pregnant or breastfeeding mothers in higher-risk families. The goal was prevention. But later evidence showed that early peanut exposure, under appropriate guidance, could substantially reduce peanut allergy risk.

The lesson is not that medicine is fake or that patients should ignore doctors. The lesson is that confident recommendations are not always the same as well-updated recommendations.

And in Southern Oregon, this matters.

When access is thin, clinician time is scarce, and patients feel pressure to say yes quickly because getting care is hard, outdated guidance can linger longer. That makes local health literacy, better patient questions, and a less defensive healthcare culture even more important.

In this episode, you’ll learn:

• Why medical blind spots form
• How cognitive dissonance affects clinicians and institutions
• Why professional identity can make evidence harder to accept
• What appendicitis reveals about surgical reflexes
• What peanut allergy teaches us about fear-based guidance
• Why updates in medical evidence can take years to reach everyday care
• How Southern Oregon patients and parents can ask better questions without becoming cynical
• Why “thoughtful trust” is healthier than blind trust or total distrust

The key question from this episode is simple:

Is this still the best evidence?

Subscribe at reimagine-healthcare.org for plain-English healthcare analysis rooted in Southern Oregon.

This podcast is for educational purposes only and is not medical advice.

America spends more on healthcare than any other wealthy country in the world — roughly twice as much per person as comparable nations.

And yet Americans, on average, die younger.

So what is going on?

In this episode of Reimagine Healthcare, Noah Volz breaks down one of the most uncomfortable paradoxes in American healthcare: the United States has extraordinary rescue medicine, advanced hospitals, high-end specialists, complex surgery, trauma care, and pharmaceutical innovation — but still struggles to create a healthier population.

The problem is not that American healthcare is bad at everything. The problem is that we built a system that is exceptionally strong once the house is already on fire, and much weaker at stopping the fire from starting in the first place.

This episode explains why life expectancy is shaped by much more than hospital care. Premature death, infant mortality, drug overdoses, firearm deaths, chronic disease, addiction, metabolic illness, mental health, food systems, housing, transportation, and daily living conditions all shape whether people live longer, healthier lives.

And because this is Reimagine Healthcare, we bring the national story home to Southern Oregon.

In Medford, Ashland, Grants Pass, Phoenix, Talent, and across the Rogue Valley, the same upstream problems show up locally: chronic disease, primary care shortages, behavioral health gaps, an aging population, lower household incomes, limited hospital competition, and employers squeezed by rising healthcare costs.

In this episode, you’ll learn:

• Why healthcare spending does not automatically create better health
• Why the U.S. performs well in rescue medicine but poorly in upstream prevention
• How premature death lowers American life expectancy
• Why insurance coverage matters, but is not enough by itself
• How chronic disease turns healthcare spending into a permanent burden
• Why Southern Oregon feels these national failures so directly
• What individuals, employers, clinicians, health systems, and civic leaders can do differently

The core takeaway is simple:

America does not mainly have a healthcare-spending problem. America has an upstream health-creation problem — and then spends enormous amounts of money managing the damage downstream.

Subscribe at reimagine-healthcare.org for plain-English healthcare analysis rooted in Southern Oregon.

This podcast is investigative health journalism for educational purposes only and is not medical advice.

Why do Americans often pay far more for the same prescription drugs than people in other wealthy countries?

In this episode of Reimagine Healthcare, Noah Volz breaks down one of the most distorted parts of the American healthcare system: prescription drug pricing.

The episode starts with a simple image: a tube of toothpaste with both ends open. Countries like Canada, the United Kingdom, Germany, and France use national purchasing power, price regulation, or formal negotiation to push drug prices down. They clamp one end of the tube. The United States mostly does not. So when manufacturers look for the market that can absorb the highest prices, the pressure often comes out here.

That means drug pricing is not just a national policy issue. It shows up in your deductible, your employer’s renewal notice, your pharmacy-counter conversation, and the coverage decisions made by public programs that serve Southern Oregon.

This episode explains:

• Why U.S. drug prices are so much higher than prices in peer countries
• How Medicare Part D changed prescription drug coverage
• Why Medicare was blocked from broad drug-price negotiation for years
• What pharmacy benefit managers, or PBMs, actually do
• How rebates can reward high sticker prices
• Why patients with high deductibles or coinsurance can be hit hardest
• Why GLP-1 drugs like Ozempic, Wegovy, Mounjaro, and Zepbound expose the system’s contradictions
• How drug costs affect Southern Oregon families, employers, Medicaid programs, and local budgets

The episode also offers practical questions for patients, clinicians, employers, and policy-minded listeners.

The main takeaway is simple: the price of a drug is not just a number. It is the output of a system.

And if that system keeps producing unaffordable access, rising premiums, and public confusion, we should stop pretending it is normal.

Subscribe at reimagine-healthcare.org for plain-English healthcare analysis rooted in Southern Oregon.

This podcast is for educational purposes only and is not medical advice.

American healthcare now costs more than $5 trillion a year — nearly one-fifth of the entire U.S. economy.

But where does all that money actually come from? And where does it go?

In this first episode of a new Reimagine Healthcare series, Noah Volz breaks down the money machine behind American healthcare in plain English. Households, employers, the federal government, and state governments all help finance the system. The money then flows through hospitals, physician groups, drug companies, insurers, administrative layers, and a web of billing rules that most people never fully see.

The result is a system that is not just expensive, but structurally expensive.

This episode explains why healthcare costs keep rising even when patients, employers, doctors, hospitals, and governments all feel under pressure. It looks at the role of employer-sponsored insurance, Medicare and Medicaid, hospital consolidation, prescription drugs, administrative complexity, chronic disease, and weak price signals.

And because this is Reimagine Healthcare, we bring the national story home to Southern Oregon.

In Medford, Ashland, Grants Pass, and across the Rogue Valley, healthcare costs shape household budgets, local business decisions, school district finances, county budgets, hiring, wages, and access to care.

In this episode, you’ll learn:

• Where America’s healthcare money comes from
• Where the money goes
• Why employer-sponsored insurance became so dominant
• Why healthcare does not behave like a normal market
• How administrative complexity drives cost
• Why chronic disease makes the system harder to finance
• Why Southern Oregon feels national healthcare inflation so directly
• What families, employers, clinicians, and civic leaders can do with this information

The point is not to give you one magic reform. It is to help you see the machine clearly enough to make better decisions.

Subscribe at reimagine-healthcare.org for more plain-English healthcare analysis rooted in Southern Oregon.

This podcast is for educational purposes only and is not medical advice.

What would it take to prevent Alzheimer’s before it becomes obvious?

In this third and final episode of our series on women’s brain health and Alzheimer’s disease, Noah Volz looks at the system Southern Oregon would need to build if it took prevention seriously.

The numbers are sobering. The lifetime cost of dementia care is estimated at more than $400,000 per person, and much of that burden falls on families through unpaid caregiving and out-of-pocket costs. Oregon already has tens of thousands of people living with Alzheimer’s, and the impact will continue to grow across families, employers, Medicaid, and local healthcare systems.

But this episode is not just about the crisis. It is about what Southern Oregon could build next.

You’ll hear five concrete asks for the region:

• A dedicated Alzheimer’s prevention clinic
• Menopause-literate primary care
• Payment models that reward prevention
• Local readiness for emerging research like the CARE Initiative
• A Southern Oregon Brain Health Coalition

The core question is simple: will Southern Oregon keep waiting until cognitive decline is obvious, or will we build a system that catches risk earlier, supports women in midlife, and makes prevention practical?

This episode is for women in midlife, primary care clinicians, healthcare administrators, payers, policymakers, and anyone who cares about the future of brain health in Southern Oregon.

Subscribe at reimagine-healthcare.org for future reporting, local events, and next steps as this conversation turns into regional action.

This podcast is for educational purposes only and is not medical advice.